找化学品上960化工网!
960化工网

人参皂苷 Rg1 | 22427-39-0

人参皂苷 Rg1
Ginsenoside RG1
22427-39-0
C42H72O14
801.0127
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:人参皂苷 Rg1结构式
329760801
人参皂苷 Rg1价格
简介
Ginsenoside Rg1 是人参的主要活性成分之一。Ginsenoside Rg1 改善认知功能受损,通过降低大脑 Aβ 水平来发挥作用。Ginsenoside Rg1 减少 NF-κB 核易位。
名称和标识符
MDL MFCD00210293
InChIKey YURJSTAIMNSZAE-HHNZYBFYSA-N
Inchi 1S/C42H72O14/c1-20(2)10-9-13-42(8,56-37-34(52)32(50)30(48)25(19-44)55-37)21-11-15-40(6)28(21)22(45)16-26-39(5)14-12-27(46)38(3,4)35(39)23(17-41(26,40)7)53-36-33(51)31(49)29(47)24(18-43)54-36/h10,21-37,43-52H,9,11-19H2,1-8H3/t21-,22+,23-,24+,25+,26+,27-,28-,29+,30+,31-,32-,33+,34+,35-,36+,37-,39+,40+,41+,42-/m0/s1
SMILES O([C@@]1([H])[C@@]([H])([C@]([H])([C@@]([H])([C@@]([H])(C([H])([H])O[H])O1)O[H])O[H])O[H])[C@@]1([H])C([H])([H])[C@]2(C([H])([H])[H])[C@]([H])(C([H])([H])[C@]([H])([C@]3([H])[C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])/C(/[H])=C(\C([H])([H])[H])/C([H])([H])[H])O[C@@]4([H])[C@@]([H])([C@]([H])([C@@]([H])([C@@]([H])(C([H])([H])O[H])O4)O[H])O[H])O[H])C([H])([H])C([H])([H])[C@@]23C([H])([H])[H])O[H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(C(C([H])([H])[H])(C([H])([H])[H])[C@@]21[H])O[H]
别名信息
- 中文别名 -
  • 人参皂苷 Rg1
  • 人参皂甙 Rg1
  • WAKO076-05021人参皂苷Rg1
  • 人参茎叶总皂苷
  • 人参提取物(西安瑞迪)
  • 人参皂苷 Rg1 Ginsenoside Rg1
  • 人参皂苷 Rg1 七叶皂苷钠 木糖醇
  • 人参皂苷 Rg1(AS)
  • 人参皂苷 Rg1(SH)
  • 人参皂苷 Rg1(标准品)
  • 人参皂苷 Rg1标准品(JP)
  • 人参皂苷-RG1
  • 人参皂苷Rg1 对照品标准品
  • 人参皂苷Rg1 USP标准品
  • 人参皂苷Rg1 标准品
  • 人参皂苷Rg1(三七皂苷C1)
  • 人参皂苷Rg1,Ginsenoside-Rg1,植物提取物,标准品,对照品
  • 人参皂苷Rg3
  • 人参皂苷Rgl
  • 人参皂苷Rk1
  • 三七叶皂苷
  • 三七总皂苷
  • 人参皂荚RG1
  • 人参皂苷Rg1
  • 人参皂苷Rg1(分析标准品)
  • 人参皂苷Rg1(对照品)
  • 人参皂苷
- 英文别名 -
  • ginsenoside rg1
  • Ginsenoside Rg1 (saponin of Panax ginseng)
  • GINSENOSIDE Rg1(AS) PrintBack
  • GINSENOSIDE Rg1(P) PrintBack
  • Ginsenoside-Rg1
  • ginsinoside Rg1
  • Ginsenoside Rg1
  • Gensenoside Rg1
  • GINSENOSIDE RGL
  • ginsenosidea2
  • ginsenosideg1
  • ginsenoside-Rg2
  • PANAXOSIDE A
  • panaxosiderg1
  • Rg1
  • SANCHINOSIDE C1
  • (3β,6α,12β)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-β-D-glucopyranoside
  • (3b,6a,12b)-3,12-Dihydroxydammar-24-ene-6,20- diylbis(beta-D-glucopyranoside)
  • Panaxoside Rg1
  • Sanchinoside Rg1
  • Ginsenoside A2
  • PJ788634QY
  • Ginsenoside g1
  • Panaxoside A
  • Ginsenoside A2
  • Ginsenoside Rg1
  • (20S)-ginsenoside Rg1
  • Dammarane, -D-glucopyranoside
  • BIDD:ER0075
  • YURJSTAIMNSZAE-HHNZYBFYSA-N
  • (2R,
  • Panaxoside A
  • Ginsenoside Rg1
  • Ginsenoside Rg1, United States Pharmacopeia (USP) Reference Standard
  • Ginsenoside Rg1, United States Pharmacopeia (USP) Reference Standard
  • GINSENOSIDE RG1 (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC]
  • GINSENOSIDE RG1 (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC]
  • GINSENOSIDE RG1 (USP-RS)
  • GINSENOSIDE RG1 (USP-RS)
  • CHEMBL501637
  • CHEMBL501637
  • Q-100285
  • Q-100285
  • A816192
  • A816192
  • Sanchinoside C1
  • Sanchinoside C1
  • GINSENOSIDE RG1 [WHO-DD]
  • GINSENOSIDE RG1 [WHO-DD]
  • (3b,6a,12b)-3,12-dihydroxydammar-24-ene-6,20- diylbis(beta-d-glucopyranoside)
  • (3b,6a,12b)-3,12-dihydroxydammar-24-ene-6,20- diylbis(beta-d-glucopyranoside)
  • Ginsenoside Rg1, primary pharmaceutical reference standard
  • Ginsenoside Rg1, primary pharmaceutical reference standard
  • CHEBI:67987
  • CHEBI:67987
  • CS-3832
  • CS-3832
  • (2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • (2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • BS-16671
  • BS-16671
  • s3923
  • s3923
  • GINSENOSIDE RG1 (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG)
  • GINSENOSIDE RG1 (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG)
  • C08946
  • C08946
  • HMS3885M12
  • HMS3885M12
  • CCG-270492
  • CCG-270492
  • HY-N0045
  • HY-N0045
  • G0533
  • G0533
  • Ginsenoside RG1
  • Ginsenoside RG1
  • (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-beta-D-Glucopyranoside
  • (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-beta-D-Glucopyranoside
  • DB06750
  • DB06750
  • NS00073634
  • NS00073634
  • NCGC00483065-01
  • NCGC00483065-01
  • RG1
  • RG1
  • AKOS037514672
  • AKOS037514672
  • 7-HYDROXY-2-OXO-2H-CHROMENE-3-CARBOXYLICACIDAMIDE
  • 7-HYDROXY-2-OXO-2H-CHROMENE-3-CARBOXYLICACIDAMIDE
  • 6-(Hexopyranosyloxy)-3,12-dihydroxydammar-24-en-20-yl hexopyranoside
  • 6-(Hexopyranosyloxy)-3,12-dihydroxydammar-24-en-20-yl hexopyranoside
  • (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20- DIYLBIS(.BETA.-D-GLUCOPYRANOSIDE)
  • (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20- DIYLBIS(.BETA.-D-GLUCOPYRANOSIDE)
  • 1ST40042
  • 1ST40042
  • beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxy dammar-24-ene-6,20-diylbis-
  • beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxy dammar-24-ene-6,20-diylbis-
  • beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diyl bis-
  • beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diyl bis-
  • (6)-beta-D-Glucopyranosyl-(20)-beta-D-glucopyranosyl-20S-protopanaxatriol
  • (6)-beta-D-Glucopyranosyl-(20)-beta-D-glucopyranosyl-20S-protopanaxatriol
  • Panaxoside A
  • Panaxoside Rg1
  • Panaxoside A
  • Panaxoside Rg1
  • EX-A6784
  • EX-A6784
  • Q2276594
  • Q2276594
  • GINSENOSIDE RG1 [USP-RS]
  • GINSENOSIDE RG1 [USP-RS]
  • MFCD00210293
  • EINECS 244-989-9
  • MFCD00210293
  • EINECS 244-989-9
  • (3beta,alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl beta-D-glucopyranoside
  • (3beta,alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl beta-D-glucopyranoside
  • GinsenosideRG1
  • GinsenosideRG1
  • SCHEMBL19875635
  • SCHEMBL19875635
  • (6)-.BETA.-D-GLUCOPYRANOSYL-(20)-.BETA.-D-GLUCOPYRANOSYL-20S- PROTOPANAXATRIOL
  • (6)-.BETA.-D-GLUCOPYRANOSYL-(20)-.BETA.-D-GLUCOPYRANOSYL-20S- PROTOPANAXATRIOL
  • ginsenoside-Rg1
  • ginsenoside-Rg1
  • .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12- DIHYDROXY DAMMAR-24-ENE-6,20-DIYLBIS-
  • .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12- DIHYDROXY DAMMAR-24-ENE-6,20-DIYLBIS-
  • .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20-DIYL BIS-
  • .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20-DIYL BIS-
  • (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diylbis(beta-D-glucopyranoside)
  • (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diylbis(beta-D-glucopyranoside)
  • UNII-PJ788634QY
  • 22427-39-0
  • UNII-PJ788634QY
  • DTXSID70945111
  • 22427-39-0
  • Ginsenoside Rg1, analytical standard
  • DTXSID70945111
  • Ginsenoside Rg1, analytical standard
  • 2-[[17-[1,5-dimethyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • Hexopyranoside, 20-(hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl
  • 20-(Hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl hexopyranoside
  • LS-15447
  • (2R,3R,4S,5S,6R)-2-[[(3S,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • DTXSID00865050
  • NSC303791
  • Dihydroxydammarane glucoside derivative
  • DIHYDROXYDAMMARENE GLUCOSIDE DERIV
  • SY068756
  • 2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • NSC-303791
  • (3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diyl bis-beta-D-glucopyranoside
  • Dammar-24-ene-3,6,12,20-tetrol
  • (3&#946
  • ,6&#945
  • ,12&#946
  • ,20S)-form, 6,20-Di-O-&#946
  • -D-glucopyranoside
物化性质
实验特性
LogP 1.11980
PSA 239.22000
沸点 898.5±65.0 °C at 760 mmHg
熔点 No data available
闪点 12 °C
颜色与性状 Powder
密度 1.3300
计算特性
精确分子量 800.49200
氢键供体数量 10
氢键受体数量 14
可旋转化学键数量 10
同位素质量 800.49220697 g/mol
重原子数量 56
复杂度 1410
同位素原子数量 0
确定原子立构中心数量 0
不确定原子立构中心数量 22
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 2.7
表面电荷 0
拓扑分子极性表面积 239
分子量 801.0
国际标准相关数据
EINECS 244-989-9
相关文献
专业数据库参考
PubChemId 329760801
人参皂苷 Rg1推荐生产厂家
960化工网为您提供人参皂苷 Rg1专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:22427-39-0,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:22427-39-0
平台客服 平台客服

平台在线客服